Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC

the Real-life Practice Experts for HCC (RELPEC) Study Group, the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

フィンガープリント

「Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Keyphrases